banner
Inquiry

Liposomes

Cat. No. Product Name Inquiry
X26-05-ZQ1560 PEG2000-modified docetaxel long-circulating liposomes (PEG-DOC-LCL)
X26-05-ZQ1561 Long-circulating PEG-Gd-DTPA liposomes
X26-05-ZQ1562 PEG surface-modified baicalin liposomes
X26-05-ZQ1563 PEG-modified adenovirus-anionic liposome complexes
X26-05-ZQ1564 Octreotide-modified PEGylated stealth liposomes
X26-05-ZQ1565 PEG-modified etoposide long-circulating liposomes (PEG-ETP LPs)
X26-05-ZQ1566 Etoposide long-circulating liposomes
X26-05-ZQ1567 Non-targeted long-circulating liposomal contrast agents (NT-PEG-Gd LPs)
X26-05-ZQ1568 Cell-penetrating peptide TA-PEG modified doxorubicin liposomes
X26-05-ZQ1569 Polyethylene glycol-modified gadopentetate dimeglumine liposomes (PEG-Gd-DTPA)
X26-05-ZQ1570 PLGA-PEG-PLGA hydrogel-encapsulated doxorubicin liposomes (DOX-Lip-Gel)
X26-05-ZQ1571 RGD co-modified liposomes (C/RGD LPs)
X26-05-ZQ1572 Cationic anticancer peptide Temporin-1 CEa liposomes
X26-05-ZQ1573 Drug carrier non-PEGylated blank liposomes
X26-05-ZQ1574 L-K6 liposomes
X26-05-ZQ1575 PEGylated dendrimer liposomes
X26-05-ZQ1576 Vincristine sulfate liposomes
X26-05-ZQ1577 PEG-RGD co-modified liposomes
X26-05-ZQ1578 PEG-modified epigallocatechin gallate/curcumin compound liposomes
X26-05-ZQ1579 PEGylated nanoliposome-encapsulated miRNA
X26-05-ZQ1580 Folate, PEG and HSA-modified IAL targeted long-circulating liposomes
X26-05-ZQ1581 DSPE-PEG(2000)-OCT containing doxorubicin stealth liposomes
X26-05-ZQ1582 Folate-PEG-human serum albumin modified isoalantolactone targeted long-circulating liposomes (f-HSA-PEG-IAL LPs)
X26-05-ZQ1583 NMFGF1-PEG+UTMD ultrasound-targeted microbubble liposomes
X26-05-ZQ1584 Cholesterol-polyethylene glycol-glycyrrhetinic acid modified liposomes (Chol-PEG-GA PLs)
X26-05-ZQ1585 Folate-PEG-liposome/vincristine (FA-PEG-LPs/VCR)
X26-05-ZQ1586 TAT-PEG multifunctional liposomes
X26-05-ZQ1587 Neuropilin-1 receptor-targeted long-circulating liposomal contrast agents (T-PEG-Gd LPs)
X26-05-ZQ1588 Gd-DTPA-encapsulated glucose-modified long-circulating liposomes
X26-05-ZQ1589 PEG-modified silymarin liposomes
X26-05-ZQ1590 PEGylated neogambogic acid liposomes (PEG-GNA LPs)
X26-05-ZQ1591 Curcumin PEGylated liposomes (Cur-PEG LPs)
X26-05-ZQ1592 PEG-modified L-K6 liposomes
X26-05-ZQ1593 Distearoylphosphatidylethanolamine-PEGylated emodin liposomes (DSPE-Emo LPs)
X26-05-ZQ1594 Gd-DTPA liposomes
X26-05-ZQ1595 PEG-modified EGCG/Cur compound liposomes
X26-05-ZQ1596 Acidic fibroblast growth factor 1-loaded PEGylated long-circulating liposomes (NMFGF1-PEG)
X26-05-ZQ1597 Anti-VEGFR2 oxaliplatin immunoliposomes
X26-05-ZQ1598 LyP-1 modified PEGylated liposomes (L-P-LS)
X26-05-ZQ1599 PEGylated epirubicin hydrochloride liposomes

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.